Izotek (Isotretinoin)

Izotek (isotretinoin) is used in dermatology to address severe forms of acne that are resistant to standard treatments.

• Severe nodular acne: reduces lesion count and prevents new nodule formation.
• Refractory acne vulgaris: clears inflammatory lesions when other therapies have failed.
• Severe cystic acne: diminishes cystic lesions and improves skin texture.

• Isotretinoin binds to nuclear retinoic acid receptors, modulating gene expression that leads to reduced sebaceous gland size and sebum production, normalization of follicular keratinization, and anti‑inflammatory effects, thereby addressing the pathogenic mechanisms of severe acne.

Isotretinoin may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

• Dry skin and mucous membranes: including cheilitis and xerosis.
• Elevated triglycerides: mild to moderate increase in blood lipids.
• Musculoskeletal discomfort: joint or muscle aches.
• Transient visual disturbances: night vision changes.
• Headache: mild to moderate intensity.

Serious or Rare Side Effects

• Severe depression or suicidal ideation.
• Inflammatory bowel disease exacerbation.
• Hepatotoxicity: significant elevation of liver enzymes.
• Pancreatitis: rare but serious.
• Teratogenic effects: birth defects if exposure occurs during pregnancy.

When prescribing isotretinoin, clinicians should observe several precautionary measures to ensure patient safety.

• Pregnancy: contraindicated; ensure effective contraception before, during, and after therapy.
• Teratogenic risk: perform pregnancy testing prior to initiation and monthly thereafter.
• Liver function: monitor hepatic enzymes regularly.
• Lipid profile: assess triglycerides and cholesterol at baseline and during treatment.
• Mood changes: watch for signs of depression or suicidal thoughts.
• Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture.

Isotretinoin can interact with other medications, affecting efficacy or increasing toxicity.

Major Interactions (Avoid)

• Tetracycline antibiotics: combined use may raise intracranial pressure risk.
• Vitamin A supplements or other retinoids: additive toxicity leading to severe side effects.
• Systemic corticosteroids: may increase risk of pseudotumor cerebri.

Moderate Interactions (Monitor Closely)

• Oral contraceptives: isotretinoin may reduce contraceptive effectiveness; advise additional barrier methods.
• Anticoagulants (e.g., warfarin): potential alteration of INR; monitor coagulation parameters.
• Phototherapy: increased photosensitivity; advise sun protection measures.